Quaking–cZFP609 Axis Remedies Aberrant Plasticity of Vascular Smooth Muscle Cells via Mediating Platelet-Derived Growth Factor Receptor β Degradation

Abstract

Vascular smooth muscle cell (VSMC) plasticity is crucial for the repair after vascular injury. However, the high plasticity of VSMCs may make them transform into pathogenic phenotypes. Here, we show that VSMCs overexpressing Sirtuin 1 (SIRT1) exhibit a reduced phenotypic plasticity in the context of platelet-derived growth factor (PDGF)-BB treatment. SIRT1 activated Quaking (QKI)–cZFP609 axis is involved in the plasticity regulation in the VSMCs. Mechanically, SIRT1 deacetylates K133 and K134 of QKI and mediates its activation. Activated QKI binds the QKI response elements located in the upstream and downstream of the cZFP609-forming exons in ZFP609 pre-mRNA to mediate cZFP609 production. Furthermore, the acetylation of QKI is increased by inhibiting SIRT1 with the selective and potent inhibitor EX527 or deletion of SIRT1, accompanied with parallel decrease in cZFP609 formation. Final, we identify that cZFP609 directs PDGF receptor (PDGFR)β sorting into endosomal/lysosomal pathway and degradation by bridging PDGFRβ and Rab7, resulted in attenuating Raf–MEK–ERK cascade activation downstream of PDGFRβ signaling. Overexpression of cZFP609 remedies aberrant plasticity and overproliferation of VSMCs, and ameliorates neointimal formation. Together, these results highlight that modulating the QKI–cZFP609 axis may help propel repair without stenosis as a therapeutic strategy in vascular injury.

Keywords

cZFP609 / neointimal hyperplasia / PDGFRβ trafficking / quaking / vascular smooth muscle cells

References

[1] L. Dobnikar, A. L. Taylor, J. Chappell, et al., “Disease-relevant Transcriptional Signatures Identified in Individual Smooth Muscle Cells From Healthy Mouse Vessels,” Nature Communications 9, no. 1 (2018): 4567.

[2] J. Chappell, J. L. Harman, V. M. Narasimhan, et al., “Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models,” Circulation Research 119, no. 12 (2016): 1313-1323.

[3] G. L. Basatemur, H. F. Jørgensen, and M. C. H. Clarke, “Vascular Smooth Muscle Cells in Atherosclerosis,” Nature Reviews Cardiology 16, no. 12 (2019): 727-744.

[4] M. O. J. Grootaert and M. R. Bennett, “Vascular Smooth Muscle Cells in Atherosclerosis: Time for a Re-assessment,” Cardiovascular Research 117, no. 11 (2021): 2326-2339.

[5] G. Cao, X. Xuan, J. Hu, R. Zhang, H. Jin, and H. Dong, “How Vascular Smooth Muscle Cell Phenotype Switching Contributes to Vascular Disease,” Cell Communication and Signaling: CCS 20, no. 1 (2022): 180.

[6] V. Sorokin, K. Vickneson, T. Kofidis, et al., “Role of Vascular Smooth Muscle Cell Plasticity and Interactions in Vessel Wall Inflammation,” Frontiers in Immunology 11 (2020): 599415.

[7] L. Li, H. N. Zhang, H. Z. Chen, et al., “Sirt1 acts as a Modulator of Neointima Formation Following Vascular Injury in Mice,” Circulation Research 108, no. 10 (2011): 1180-1189.

[8] S. Ma, S. M. Motevalli, J. Chen, et al., “Precise Theranostic Nanomedicines for Inhibiting Vulnerable Atherosclerotic Plaque Progression Through Regulation of Vascular Smooth Muscle Cell Phenotype Switching,” Theranostics 8, no. 13 (2018): 3693-3706.

[9] I. Gorenne, S. Kumar, K. Gray, et al., “Vascular Smooth Muscle Cell Sirtuin 1 Protects Against DNA Damage and Inhibits Atherosclerosis,” Circulation 127, no. 3 (2013): 386-396.

[10] Y. Yang, W. Duan, Y. Li, et al., “Novel Role of Silent Information Regulator 1 in Myocardial Ischemia,” Circulation 128, no. 20 (2013): 2232-2240.

[11] Y. Q. Dou, P. Kong, C. L. Li, et al., “Smooth Muscle sirt1 Reprograms Endothelial Cells to Suppress Angiogenesis After Ischemia,” Theranostics 10, no. 3 (2020): 1197-1212.

[12] A. W. Heumüller and S. Dimmeler, “Circular Rna Control of Vascular Smooth Muscle Cell Functions,” Circulation Research 124, no. 4 (2019): 456-458.

[13] R. G. de Bruin, T. J. Rabelink, A. J. van Zonneveld, and E. P. van der Veer, “Emerging Roles for Rna-binding Proteins as Effectors and Regulators of Cardiovascular Disease,” European Heart Journal 38, no. 18 (2017): 1380-1388.

[14] S. J. Conn, K. A. Pillman, J. Toubia, et al., “The Rna Binding Protein Quaking Regulates Formation of Circrnas,” Cell 160, no. 6 (2015): 1125-1134.

[15] M. J. Justice and K. K. Hirschi, “The Role of Quaking in Mammalian Embryonic Development,” Advances in Experimental Medicine and Biology 693 (2010): 82-92.

[16] D. P. Neumann, G. J. Goodall, and P. A. Gregory, “The Quaking Rna-binding Proteins as Regulators of Cell Differentiation,” Wiley Interdisciplinary Reviews RNA 13, no. 6 (2022): e1724.

[17] E. P. van der Veer, R. G. de Bruin, A. O. Kraaijeveld, et al., “Quaking, an Rna-binding Protein, Is a Critical Regulator of Vascular Smooth Muscle Cell Phenotype,” Circulation Research 113, no. 9 (2013): 1065-1075.

[18] R. Caines, A. Cochrane, S. Kelaini, et al., “The Rna-binding Protein qki Controls Alternative Splicing in Vascular Cells, Producing an Effective Model for Therapy,” Journal of Cell Science 132, no. 16 (2019).

[19] R. Ashwal-Fluss, M. Meyer, N. R. Pamudurti, et al., “Circrna Biogenesis Competes With Pre-mrna Splicing,” Molecular Cell 56, no. 1 (2014): 55-66.

[20] A. Galarneau and S. Richard, “Target Rna Motif and Target Mrnas of the Quaking Star Protein,” Nature Structural & Molecular Biology 12, no. 8 (2005): 691-698.

[21] K. Bockbrader and Y. Feng, “Essential Function, Sophisticated Regulation and Pathological Impact of the Selective Rna-binding Protein Qki in Cns Myelin Development,” Future Neurology 3, no. 6 (2008): 655-668.

[22] W. Zhang, Y. Sun, W. Liu, J. Dong, and J. Chen, “Sirt1 mediates the Role of Rna-binding Protein Qki 5 in the Synthesis of Triglycerides in Non-alcoholic Fatty Liver Disease Mice via the Pparα/foxo1 Signaling Pathway,” International Journal of Molecular Medicine 43, no. 3 (2019): 1271-1280.

[23] L.-H. Dong, J.-K. Wen, G. Liu, et al., “Blockade of the Ras-extracellular Signal-regulated Kinase 1/2 Pathway Is Involved in Smooth Muscle 22α-mediated Suppression of Vascular Smooth Muscle Cell Proliferation and Neointima Hyperplasia,” Arteriosclerosis, Thrombosis, and Vascular Biology 30, no. 4 (2010): 683-691.

[24] L. Chang and M. Karin, “Mammalian Map Kinase Signalling Cascades,” Nature 410, no. 6824 (2001): 37-40.

[25] M. G. Sirois, M. Simons, and E. R. Edelman, “Antisense Oligonucleotide Inhibition of Pdgfr-beta Receptor Subunit Expression Directs Suppression of Intimal Thickening,” Circulation 95, no. 3 (1997): 669-676.

[26] S. Marshall, A. Green, and J. M. Olefsky, “Evidence for Recycling of Insulin Receptors in Isolated Rat Adipocytes,” Journal of Biological Chemistry 256, no. 22 (1981): 11464-11470.

[27] J. Nilsson, J. Thyberg, C. H. Heldin, B. Westermark, and A. Wasteson, “Surface Binding and Internalization of Platelet-derived Growth Factor in human Fibroblasts,” Proceedings National Academy of Sciences of the United States of America 80, no. 18 (1983): 5592-5596.

[28] M. E. Rosenfeld, D. F. Bowen-Pope, and R. Ross, “Platelet-derived Growth Factor: Morphologic and Biochemical Studies of Binding, Internalization, and Degradation,” Journal of Cellular Physiology 121, no. 2 (1984): 263-274.

[29] R. Kapeller, R. Chakrabarti, L. Cantley, F. Fay, and S. Corvera, “Internalization of Activated Platelet-derived Growth Factor Receptor-phosphatidylinositol-3' kinase Complexes: Potential Interactions With the Microtubule Cytoskeleton,” Molecular and Cellular Biology 13, no. 10 (1993): 6052-6063.

[30] S. Mukherjee, M. Tessema, and A. Wandinger-Ness, “Vesicular Trafficking of Tyrosine Kinase Receptors and Associated Proteins in the Regulation of Signaling and Vascular Function,” Circulation Research 98, no. 6 (2006): 743-756.

[31] M. A. Rogers and K. A. Fantauzzo, “The Emerging Complexity of Pdgfrs: Activation, Internalization and Signal Attenuation,” Biochemical Society Transactions 48, no. 3 (2020): 1167-1176.

[32] S. Miyake, M. L. Lupher, B. Druker, and H. Band, “The Tyrosine Kinase Regulator Cbl Enhances the Ubiquitination and Degradation of the Platelet-derived Growth Factor Receptor Alpha,” Proceedings National Academy of Science of the United States of America 95, no. 14 (1998): 7927-7932.

[33] J. I. Wu, R. B. Reed, P. J. Grabowski, and K. Artzt, “Function of Quaking in Myelination: Regulation of Alternative Splicing,” Proceedings National Academy of Science of the United States of America 99, no. 7 (2002): 4233-4238.

[34] J. Côté, F. M. Boisvert, M. C. Boulanger, M. T. Bedford, and S. Richard, “Sam68 rna Binding Protein Is an in Vivo Substrate for Protein Arginine n-methyltransferase 1,” Molecular Biology of the Cell 14, no. 1 (2003): 274-287.

[35] Y. Zhang, Z. Lu, L. Ku, Y. Chen, H. Wang, and Y. Feng, “Tyrosine Phosphorylation of qki Mediates Developmental Signals to Regulate mrna Metabolism,” Embo Journal 22, no. 8 (2003): 1801-1810.

[36] R. G. de Bruin, L. Shiue, J. Prins, et al., “Quaking Promotes Monocyte Differentiation Into Pro-atherogenic Macrophages by Controlling Pre-mrna Splicing and Gene Expression,” Nature Communications 7 (2016): 10846.

[37] Y. Wang, G. Vogel, Z. Yu, and S. Richard, “The Qki-5 and Qki-6 Rna Binding Proteins Regulate the Expression of Microrna 7 in Glial Cells,” Molecular and Cellular Biology 33, no. 6 (2013): 1233-1243.

[38] F. Wang, W. Song, H. Zhao, et al., “The Rna-binding Protein qki5 Regulates Primary Mir-124-1 Processing via a Distal Rna Motif During Erythropoiesis,” Cell Research 27, no. 3 (2017): 416-439.

[39] W. R. Jeck and N. E. Sharpless, “Detecting and Characterizing Circular Rnas,” Nature Biotechnology 32, no. 5 (2014): 453-461.

[40] W. Y. Zhou, Z. R. Cai, J. Liu, D. S. Wang, H. Q. Ju, and R. H. Xu, “Circular Rna: Metabolism, Functions and Interactions With Proteins,” Molecular Cancer 19, no. 1 (2020): 172.

[41] L. M. Holdt, A. Stahringer, K. Sass, et al., “Circular Non-coding Rna Anril Modulates Ribosomal Rna Maturation and Atherosclerosis in Humans,” Nature Communications 7 (2016): 12429.

[42] Z. Zeng, L. Xia, S. Fan, et al., “Circular rna circmap3k5 Acts as a Microrna-22-3p Sponge to Promote Resolution of Intimal Hyperplasia via tet2-mediated Smooth Muscle Cell Differentiation,” Circulation 143, no. 4 (2021): 354-371.

[43] P. Kong, Y. Yu, L. Wang, et al., “Circ-sirt1 Controls Nf-κb Activation via Sequence-specific Interaction and Enhancement of sirt1 Expression by Binding to Mir-132/212 in Vascular Smooth Muscle Cells,” Nucleic Acids Research 47, no. 7 (2019): 3580-3593.

[44] I. F. Hall, M. Climent, M. Quintavalle, et al., “Circ_lrp6, a Circular Rna Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating Mirna-145 Function,” Circulation Research 124, no. 4 (2019): 498-510.

[45] X. Chen, J. Yin, D. Cao, et al., “The Emerging Roles of the Rna Binding Protein Qki in Cardiovascular Development and Function,” Frontiers in Cell and Developmental Biology 9 (2021): 668659.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.